| 8pzb |
crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 49 |
19.3 |
62.2 |
X-RAY DIFFRACTION |
GOOD
|
| 8pzg |
Metagenomic lipase ORF17 |
27.4 |
73.5 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8pzh |
LpdD (H61A) mutant |
20.6 |
69.3 |
X-RAY DIFFRACTION |
GOOD
|
| 8pzk |
Crystal structure of the Orange Carotenoid Protein 2 (OCP2) from Gloeocapsa sp. PCC 7428 |
21.6 |
70.3 |
X-RAY DIFFRACTION |
GOOD
|
| 8pzm |
Intracellular leucine aminopeptidase of Pseudomonas aeruginosa PA14 bound to bestatin inhibitor and manganese |
25.3 |
85.6 |
X-RAY DIFFRACTION |
GOOD
|
| 8pzo |
LpdD |
20.9 |
69.1 |
X-RAY DIFFRACTION |
GOOD
|
| 8pzp |
Model for influenza A virus helical ribonucleoprotein-like structure |
26.1 |
95.2 |
ELECTRON MICROSCOPY |
GOOD
|
| 8pzq |
Model for focused reconstruction of influenza A RNP-like particle |
40.0 |
137.8 |
ELECTRON MICROSCOPY |
GOOD
|
| 8pzu |
Wait Complex: BAM bound Darobactin-B and Compact SurA |
45.0 |
146.6 |
ELECTRON MICROSCOPY |
GOOD
|
| 8pzv |
Wait Complex: BAM bound Darobactin-B and Extended SurA |
43.1 |
137.3 |
ELECTRON MICROSCOPY |
GOOD
|
| 8pzy |
Intracellular leucine aminopeptidase of Pseudomonas aeruginosa PA14 - hexameric assembly with manganese bound |
44.0 |
139.8 |
X-RAY DIFFRACTION |
GOOD
|
| 8q00 |
TssM-Ub-PA complex - A USP-like DUB from B. pseudomallei (193-430) reacted with Ub-PA |
32.1 |
104.3 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q01 |
Neck of phage 812 after tail contraction (C6) |
66.2 |
224.4 |
ELECTRON MICROSCOPY |
SUSPICIOUS
|
| 8q03 |
Metagenomic lipase ORF30 |
34.7 |
114.7 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q04 |
Chlorella sorokiniana Rubisco: D4 symmetry imposed |
46.6 |
137.3 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q05 |
Chlorella sorokiniana Rubisco with CsLinker (alpha3-alpha4) bound: D4 symmetry expanded |
46.7 |
136.6 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q06 |
EF-hand of MINDY3 Deubiquitylase in Complex with UBL of RAD23A |
23.7 |
76.6 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 8q0a |
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM. |
80.5 |
217.1 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0c |
Human carbonic anhydrase II containing 3-fluorotyrosine |
18.6 |
58.7 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0e |
Crystal Structure of the N-terminal Domain of Variant Surface Glycoprotein 545 (VSG545) of Trypanosome brucei brucei Lister 427 |
30.1 |
109.7 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q0f |
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM. |
81.1 |
218.7 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0g |
Release Complex: BAM bound EspP and Compact SurA |
49.1 |
156.2 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0j |
Inward-facing, slack proteoliposome complex I at 3.8 A. Initially purified in DDM. |
83.1 |
222.5 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0m |
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM. |
80.7 |
217.6 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0n |
HACE1 in complex with RAC1 Q61L |
37.2 |
129.3 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0o |
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM. |
81.2 |
219.1 |
ELECTRON MICROSCOPY |
REASONABLE
|
| 8q0p |
Crystal Structure of an N-terminal Domain of Variant Surface Glycoprotein 21 (VSG21) of Trypanosome brucei brucei Lister 427 |
39.8 |
120.3 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q0q |
Outward-facing, slack proteoliposome complex I at 3.6 A. Initially purified in DDM |
83.6 |
223.9 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q0r |
X-ray structure of MNEI mutant Mut9 (E23A, C41A, Y65R, S76Y) |
19.1 |
58.5 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q0s |
X-ray structure of the single chain monellin derivative MNEI |
19.0 |
60.8 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0t |
;Identification and optimisation of novel inhibitors of the Polyketide synthetase 13 thioesterase domain with antitubercular activity
; |
28.2 |
92.3 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0u |
;Identification and optimisation of novel inhibitors of the Polyketide synthetase 13 thioesterase domain with antitubercular activity
; |
28.0 |
89.6 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0v |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)-5-(3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-073)
; |
20.4 |
64.7 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0w |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-((allyl(methyl)amino)methyl)thiazol-4-yl)-5-(3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-086)
; |
20.4 |
65.1 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0x |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-((methyl(propyl)amino)methyl)thiazol-4-yl)-5-(3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-087)
; |
20.4 |
64.7 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0y |
;Endothiapepsin in complex with ligand (3R,5R)-5-(3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)pyrrolidin-3-ol (CBWS-SE-085.1)
; |
20.3 |
64.9 |
X-RAY DIFFRACTION |
GOOD
|
| 8q0z |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)-5-(3-phenyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-089)
; |
20.3 |
64.8 |
X-RAY DIFFRACTION |
GOOD
|
| 8q10 |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-(hydroxymethyl)thiazol-4-yl)-5-(3-(4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-125)
; |
20.3 |
65.6 |
X-RAY DIFFRACTION |
GOOD
|
| 8q11 |
;Endothiapepsin in complex with ligand (3R,5R)-5-(3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)pyrrolidin-3-ol (CBWS-SE-126)
; |
20.3 |
64.8 |
X-RAY DIFFRACTION |
GOOD
|
| 8q12 |
;Endothiapepsin in complex with ligand (3R,5R)-5-(3-(2-aminophenyl)-1,2,4-oxadiazol-5-yl)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)pyrrolidin-3-ol (CBWS-SE-146.2)
; |
20.2 |
64.7 |
X-RAY DIFFRACTION |
GOOD
|
| 8q13 |
;Endothiapepsin in complex with ligand (3R,5R)-5-(3-(2-amino-4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)pyrrolidin-3-ol (CBWS-SE-168)
; |
20.3 |
64.5 |
X-RAY DIFFRACTION |
GOOD
|
| 8q14 |
;Endothiapepsin in complex with ligand (3R,5R)-3-(2-((methyl(prop-2-yn-1-yl)amino)methyl)thiazol-4-yl)-5-(3-(2-nitro-4-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)pyrrolidin-3-ol (CBWS-SE-171)
; |
20.3 |
64.0 |
X-RAY DIFFRACTION |
GOOD
|
| 8q15 |
CryoEM structure of canonical rice nucleosome core particle |
39.0 |
114.3 |
ELECTRON MICROSCOPY |
EXCELLENT
|
| 8q16 |
CryoEM structure of rice nucleosome containing a H4 variant chimera |
40.6 |
116.6 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q17 |
;Identification and optimisation of novel inhibitors of the Polyketide synthetase 13 thioesterase domain with antitubercular activity
; |
28.3 |
90.0 |
X-RAY DIFFRACTION |
REASONABLE
|
| 8q18 |
The Crystal Structure of Human Carbonic Anhydrase IX in Complex with Sulfonamide |
32.4 |
101.3 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 8q19 |
The Crystal Structure of Human Carbonic Anhydrase IX in Complex with Sulfonamide |
32.4 |
99.6 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 8q1a |
The Crystal Structure of Human Carbonic Anhydrase IX in Complex with inhibitor |
32.4 |
100.2 |
X-RAY DIFFRACTION |
EXCELLENT
|
| 8q1b |
III2-IV1 respiratory supercomplex from S. pombe |
67.2 |
261.5 |
ELECTRON MICROSCOPY |
GOOD
|
| 8q1c |
Substrate-free D10N,P146A variant of beta-phosphoglucomutase from Lactococcus lactis |
25.6 |
76.7 |
X-RAY DIFFRACTION |
EXCELLENT
|